ANKRD13C
gene geneOn this page
Also known as DKFZP566D1346dJ677H15.3
Summary
ANKRD13C (ankyrin repeat domain 13C, HGNC:25374) is a protein-coding gene on chromosome 1p31.1, encoding Ankyrin repeat domain-containing protein 13C (Q8N6S4). Acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER.
Enables signaling receptor binding activity. Involved in protein retention in ER lumen; regulation of anoikis; and regulation of signaling receptor activity. Located in endoplasmic reticulum and perinuclear region of cytoplasm.
Source: NCBI Gene 81573 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 71 total — 2 pathogenic
- MANE Select transcript:
NM_030816
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25374 |
| Approved symbol | ANKRD13C |
| Name | ankyrin repeat domain 13C |
| Location | 1p31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP566D1346, dJ677H15.3 |
| Ensembl gene | ENSG00000118454 |
| Ensembl biotype | protein_coding |
| OMIM | 615125 |
| Entrez | 81573 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 17 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000262346, ENST00000370944, ENST00000464236, ENST00000490846, ENST00000498735, ENST00000888125, ENST00000888126, ENST00000888127, ENST00000888128, ENST00000888130, ENST00000888131, ENST00000888134, ENST00000888140, ENST00000888143, ENST00000927582, ENST00000927583, ENST00000927584, ENST00000927585, ENST00000970447, ENST00000970448
RefSeq mRNA: 1 — MANE Select: NM_030816
NM_030816
CCDS: CCDS648
Canonical transcript exons
ENST00000370944 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000798468 | 70276765 | 70276844 |
| ENSE00000798469 | 70292388 | 70292549 |
| ENSE00000995737 | 70258999 | 70262847 |
| ENSE00000995739 | 70336058 | 70336099 |
| ENSE00001931107 | 70353979 | 70354722 |
| ENSE00003467607 | 70324853 | 70324957 |
| ENSE00003507082 | 70313745 | 70313790 |
| ENSE00003510539 | 70270856 | 70270956 |
| ENSE00003540444 | 70296130 | 70296261 |
| ENSE00003590621 | 70300764 | 70300908 |
| ENSE00003592663 | 70315481 | 70315566 |
| ENSE00003632660 | 70306224 | 70306290 |
| ENSE00003679816 | 70274720 | 70274818 |
Expression profiles
Bgee: expression breadth ubiquitous, 254 present calls, max score 96.54.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.1175 / max 169.5902, expressed in 1812 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12807 | 21.6685 | 1812 |
| 12806 | 0.2808 | 127 |
| 12808 | 0.1683 | 73 |
Top tissues by expression
257 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 96.54 | gold quality |
| colonic epithelium | UBERON:0000397 | 89.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 89.08 | gold quality |
| tibia | UBERON:0000979 | 88.90 | gold quality |
| adrenal tissue | UBERON:0018303 | 88.47 | gold quality |
| endothelial cell | CL:0000115 | 88.23 | gold quality |
| cortical plate | UBERON:0005343 | 88.19 | gold quality |
| tendon | UBERON:0000043 | 87.85 | gold quality |
| corpus callosum | UBERON:0002336 | 87.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 86.81 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.58 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.54 | gold quality |
| parietal pleura | UBERON:0002400 | 86.27 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.25 | gold quality |
| eye | UBERON:0000970 | 85.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.32 | gold quality |
| visceral pleura | UBERON:0002401 | 85.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.94 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.78 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.75 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 84.61 | gold quality |
| ventricular zone | UBERON:0003053 | 84.57 | gold quality |
| endometrium | UBERON:0001295 | 84.56 | gold quality |
| buccal mucosa cell | CL:0002336 | 84.55 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.51 | gold quality |
| sural nerve | UBERON:0015488 | 84.46 | gold quality |
| cerebellum | UBERON:0002037 | 84.35 | gold quality |
| upper arm skin | UBERON:0004263 | 84.35 | gold quality |
| muscle of leg | UBERON:0001383 | 84.15 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
264 targeting ANKRD13C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
Literature-anchored findings (GeneRIF, showing 1)
- ANKRD13C acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER. (PMID:20959461)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ankrd13c | ENSDARG00000103831 |
| mus_musculus | Ankrd13c | ENSMUSG00000039988 |
| rattus_norvegicus | Ankrd13c | ENSRNOG00000011340 |
| rattus_norvegicus | LOC102553980 | ENSRNOG00000061420 |
| drosophila_melanogaster | CG5742 | FBGN0034304 |
| caenorhabditis_elegans | WBGENE00015301 |
Paralogs (3): ANKRD13A (ENSG00000076513), ANKRD13D (ENSG00000172932), ANKRD13B (ENSG00000198720)
Protein
Protein identifiers
Ankyrin repeat domain-containing protein 13C — Q8N6S4 (reviewed: Q8N6S4)
All UniProt accessions (1): Q8N6S4
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER.
Subcellular location. Endoplasmic reticulum membrane.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N6S4-1 | 1 | yes |
| Q8N6S4-2 | 2 | |
| Q8N6S4-3 | 3 |
RefSeq proteins (1): NP_110443* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR021832 | ANKRD13 | Family |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR055285 | ANKRD13_C | Domain |
Pfam: PF11904, PF12796
UniProt features (12 total): repeat 3, splice variant 3, chain 1, sequence variant 1, sequence conflict 1, region of interest 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6S4-F1 | 75.71 | 0.44 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 411
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 192 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, TGGTGCT_MIR29A_MIR29B_MIR29C, GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS, GOBP_PROTEIN_TARGETING, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_PROTEIN_TARGETING_TO_MEMBRANE, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_PROSTAGLANDIN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_RESPONSE_TO_KETONE, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, GOBP_RESPONSE_TO_HORMONE
GO Biological Process (3): protein targeting to membrane (GO:0006612), cellular response to prostaglandin D stimulus (GO:0071799), regulation of anoikis (GO:2000209)
GO Molecular Function (3): signaling receptor binding (GO:0005102), protein carrier activity (GO:0140597), protein binding (GO:0005515)
GO Cellular Component (5): cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), perinuclear region of cytoplasm (GO:0048471), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 2 |
| protein targeting | 1 |
| establishment of protein localization to membrane | 1 |
| cellular response to prostaglandin stimulus | 1 |
| response to prostaglandin D | 1 |
| cellular response to alcohol | 1 |
| cellular response to ketone | 1 |
| regulation of apoptotic process | 1 |
| anoikis | 1 |
| protein binding | 1 |
| molecular carrier activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
Protein interactions and networks
STRING
850 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD13C | M0QYU9 | M0QYU9 | 512 |
| ANKRD13C | SMIM7 | Q9BQ49 | 499 |
| ANKRD13C | RTP4 | Q96DX8 | 443 |
| ANKRD13C | C2orf69 | Q8N8R5 | 429 |
| ANKRD13C | G3V325 | G3V325 | 419 |
| ANKRD13C | KIAA1328 | Q86T90 | 411 |
| ANKRD13C | C5orf24 | Q7Z6I8 | 400 |
| ANKRD13C | FASTKD3 | Q14CZ7 | 391 |
| ANKRD13C | TYW3 | Q6IPR3 | 382 |
| ANKRD13C | VSTM4 | Q8IW00 | 379 |
| ANKRD13C | MGAT4C | Q9UBM8 | 373 |
| ANKRD13C | ARL5A | Q9Y689 | 369 |
| ANKRD13C | ZCCHC10 | Q8TBK6 | 367 |
| ANKRD13C | MYDGF | Q969H8 | 348 |
| ANKRD13C | ATAD3C | Q5T2N8 | 348 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ANKRD13C | CLDND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MANSC1 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| DLK1 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| KCNS3 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| CPLX2 | DEGS1 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A15 | ZFPL1 | psi-mi:“MI:0914”(association) | 0.530 |
| DLK1 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.530 |
| NRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.480 |
| CAV3 | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC18A1 | LIMK2 | psi-mi:“MI:0914”(association) | 0.350 |
| NTRK3 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| GRIN1 | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC18A1 | UBXN8 | psi-mi:“MI:0914”(association) | 0.350 |
| MARCHF4 | C2CD2L | psi-mi:“MI:0914”(association) | 0.350 |
| FUNDC2 | ALDH1A1 | psi-mi:“MI:0914”(association) | 0.350 |
| GPR27 | TMEM259 | psi-mi:“MI:0914”(association) | 0.350 |
| DLK1 | PLPP3 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC7A7 | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| KRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CLDND2 | ANKRD13C | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (32): ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-RNA), ANKRD13C (Proximity Label-MS), CLDND2 (Two-hybrid), ANKRD13C (Proximity Label-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS), ANKRD13C (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IES7, A0JN62, A0JNW5, A2AAE1, A2AGL3, A2RSJ4, A2RT67, A2RUS2, A2RV80, B0LPN4, B1H2P5, E7F240, E9Q401, O00507, O94967, P30957, P48553, P51593, Q14161, Q2LD37, Q3TLI0, Q3UHE1, Q3UVG3, Q3UX43, Q5F361, Q5M7Q1, Q5RAQ5, Q5ZJK1, Q658Y4, Q68CL5, Q6BDS2, Q6P6Y1, Q6TEP1, Q6VNB8, Q7TMY8, Q7TSG1, Q7Z6Z7, Q8BHY8, Q8CB44, Q8CGF6
Diamond homologs: A0A0R4IQZ2, A2AS55, A4II29, B4E2M5, C7B178, G0LXV8, L7X8P2, L7XCU0, L7XDS4, P0C0T2, P0C550, P0DJE3, P19838, P23631, P39010, Q04749, Q04861, Q0JKV1, Q10728, Q18297, Q28C34, Q337A0, Q38998, Q3SX00, Q3UMT1, Q3UX43, Q499M5, Q4JHE0, Q5H9F3, Q5R8C8, Q5U5A6, Q63369, Q68DC2, Q6FJ70, Q6GQX6, Q6NRD0, Q6NY19, Q6P6B7, Q6P9J5, Q6ZVH7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 58079 | GRCh38/hg38 1p32.3-31.1(chr1:52595352-76767765)x3 | Pathogenic |
| 59972 | GRCh38/hg38 1p31.3-31.1(chr1:67239704-71924806)x1 | Pathogenic |
SpliceAI
2987 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:70274718:A:AC | donor_gain | 1.0000 |
| 1:70274719:C:CC | donor_gain | 1.0000 |
| 1:70274719:CAA:C | donor_gain | 1.0000 |
| 1:70274719:CAACT:C | donor_gain | 1.0000 |
| 1:70276758:AACTT:A | donor_loss | 1.0000 |
| 1:70276759:ACTTA:A | donor_loss | 1.0000 |
| 1:70276760:CTTAC:C | donor_loss | 1.0000 |
| 1:70276761:TTAC:T | donor_loss | 1.0000 |
| 1:70276762:TACT:T | donor_loss | 1.0000 |
| 1:70276763:A:AC | donor_gain | 1.0000 |
| 1:70276763:ACTTT:A | donor_gain | 1.0000 |
| 1:70276764:C:CA | donor_gain | 1.0000 |
| 1:70276764:CT:C | donor_gain | 1.0000 |
| 1:70276764:CTT:C | donor_gain | 1.0000 |
| 1:70276764:CTTT:C | donor_gain | 1.0000 |
| 1:70276764:CTTTC:C | donor_gain | 1.0000 |
| 1:70276767:T:A | donor_gain | 1.0000 |
| 1:70276840:ATCGG:A | acceptor_gain | 1.0000 |
| 1:70276841:TCGG:T | acceptor_gain | 1.0000 |
| 1:70276842:CGG:C | acceptor_gain | 1.0000 |
| 1:70276842:CGGC:C | acceptor_gain | 1.0000 |
| 1:70276843:GG:G | acceptor_gain | 1.0000 |
| 1:70276845:C:CC | acceptor_gain | 1.0000 |
| 1:70276849:C:CT | acceptor_gain | 1.0000 |
| 1:70276849:C:T | acceptor_gain | 1.0000 |
| 1:70276850:A:T | acceptor_gain | 1.0000 |
| 1:70292382:TTATA:T | donor_loss | 1.0000 |
| 1:70292383:TATAC:T | donor_loss | 1.0000 |
| 1:70292387:C:CA | donor_loss | 1.0000 |
| 1:70292545:CTTTC:C | acceptor_gain | 1.0000 |
AlphaMissense
3571 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:70262820:G:T | A508D | 1.000 |
| 1:70262821:C:G | A508P | 1.000 |
| 1:70270867:G:T | P495H | 1.000 |
| 1:70270869:A:C | F494L | 1.000 |
| 1:70270869:A:T | F494L | 1.000 |
| 1:70270871:A:G | F494L | 1.000 |
| 1:70274753:G:T | A454D | 1.000 |
| 1:70274800:T:A | R438S | 1.000 |
| 1:70274800:T:G | R438S | 1.000 |
| 1:70274801:C:G | R438T | 1.000 |
| 1:70276786:T:C | Y425C | 1.000 |
| 1:70276787:A:C | Y425D | 1.000 |
| 1:70276787:A:G | Y425H | 1.000 |
| 1:70276796:A:G | W422R | 1.000 |
| 1:70276796:A:T | W422R | 1.000 |
| 1:70292470:A:G | L378P | 1.000 |
| 1:70292470:A:T | L378H | 1.000 |
| 1:70292472:A:C | H377Q | 1.000 |
| 1:70292472:A:T | H377Q | 1.000 |
| 1:70292473:T:C | H377R | 1.000 |
| 1:70292474:G:C | H377D | 1.000 |
| 1:70292477:C:T | E376K | 1.000 |
| 1:70292478:T:A | R375S | 1.000 |
| 1:70292478:T:G | R375S | 1.000 |
| 1:70292481:T:A | R374S | 1.000 |
| 1:70292481:T:G | R374S | 1.000 |
| 1:70292482:C:A | R374I | 1.000 |
| 1:70292482:C:G | R374T | 1.000 |
| 1:70292483:T:C | R374G | 1.000 |
| 1:70292484:T:A | K373N | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000006114 (1:70321041 G>T), RS1000017914 (1:70268178 C>T), RS1000046756 (1:70287894 C>T), RS1000060852 (1:70280998 A>G), RS1000068370 (1:70350730 ATACT>A), RS1000069102 (1:70327474 G>A), RS1000145240 (1:70261951 T>C), RS1000150539 (1:70299879 C>G), RS1000156276 (1:70294274 T>C,G), RS1000157624 (1:70316251 T>C,G), RS1000196178 (1:70305086 T>C), RS1000208440 (1:70353957 G>A,C,T), RS1000226569 (1:70354228 G>A,C), RS1000230704 (1:70315716 C>A), RS1000238578 (1:70334695 C>T)
Disease associations
OMIM: gene MIM:615125 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 4 |
| Nickel | increases expression | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects expression | 1 |
| deoxynivalenol | increases expression | 1 |
| salinomycin | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, increases expression | 1 |
| Indomethacin | decreases expression | 1 |
| Lead | affects expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Theophylline | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.